Influence of local radiotherapy of breast cancer patients on the frequency of cytotoxic T lymphocyte precursor cells. 1990

M Berger, and E Irschick, and E Fritsch, and H Frommhold, and D Schönitzer, and J Wiegele, and G Kemmler, and C Huber
Department of Internal Medicine, University Hospital Innsbruck, Austria.

Alloantigen-specific cytotoxic T lymphocyte precursor (CTL-p) frequencies were analyzed in ten patients with histologically proven breast cancer receiving prophylactic RT. The frequency of CTL-p was assessed by limiting dilution (LD) analyses before, immediately after discontinuation of treatment and at various times following RT. The number of pbmnc, adherent cells and T cells was determined in parallel. Local RT led to a minor and transient reduction of CTL-p frequencies lasting approximately three months: on average a 25% decrease of CTL-p numbers was seen immediately after RT. Three months following treatment, a 20% reduction was still evident. Values subsequently returned to pretreatment levels. Moreover, these changes in the frequency of antigen-specific CTL were accompanied by a 25% to 39% decrease in the blood T cell counts lasting for more than 12 months. The reductions following local RT were less pronounced than those induced by immunosuppressive drugs in allograft recipients.

UI MeSH Term Description Entries
D007153 Immunologic Deficiency Syndromes Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral. Antibody Deficiency Syndrome,Deficiency Syndrome, Immunologic,Deficiency Syndromes, Antibody,Deficiency Syndromes, Immunologic,Immunologic Deficiency Syndrome,Immunological Deficiency Syndromes,Antibody Deficiency Syndromes,Deficiency Syndrome, Antibody,Deficiency Syndrome, Immunological,Deficiency Syndromes, Immunological,Immunological Deficiency Syndrome,Syndrome, Antibody Deficiency,Syndrome, Immunologic Deficiency,Syndrome, Immunological Deficiency,Syndromes, Antibody Deficiency,Syndromes, Immunologic Deficiency,Syndromes, Immunological Deficiency
D007970 Leukopenia A decrease in the number of LEUKOCYTES in a blood sample below the normal range (LEUKOCYTE COUNT less than 4000). Leukocytopenia,Leukocytopenias,Leukopenias
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011867 Radioisotope Teletherapy A type of high-energy radiotherapy using a beam of gamma-radiation produced by a radioisotope source encapsulated within a teletherapy unit. Teleradioisotope Therapy,Teletherapy, Radioisotope,Therapy, Teleradioisotope
D011882 Radiotherapy, High-Energy Radiotherapy using high-energy (megavolt or higher) ionizing radiation. Types of radiation include gamma rays, produced by a radioisotope within a teletherapy unit; x-rays, electrons, protons, alpha particles (helium ions) and heavy charged ions, produced by particle acceleration; and neutrons and pi-mesons (pions), produced as secondary particles following bombardment of a target with a primary particle. Megavolt Radiotherapy,High-Energy Radiotherapy,Radiotherapy, Megavolt,High Energy Radiotherapy,Radiotherapy, High Energy
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

M Berger, and E Irschick, and E Fritsch, and H Frommhold, and D Schönitzer, and J Wiegele, and G Kemmler, and C Huber
November 1986, Cellular immunology,
M Berger, and E Irschick, and E Fritsch, and H Frommhold, and D Schönitzer, and J Wiegele, and G Kemmler, and C Huber
June 2014, Oncology letters,
M Berger, and E Irschick, and E Fritsch, and H Frommhold, and D Schönitzer, and J Wiegele, and G Kemmler, and C Huber
January 1988, Cellular immunology,
M Berger, and E Irschick, and E Fritsch, and H Frommhold, and D Schönitzer, and J Wiegele, and G Kemmler, and C Huber
October 2007, Hua xi kou qiang yi xue za zhi = Huaxi kouqiang yixue zazhi = West China journal of stomatology,
M Berger, and E Irschick, and E Fritsch, and H Frommhold, and D Schönitzer, and J Wiegele, and G Kemmler, and C Huber
November 2005, Transplantation,
M Berger, and E Irschick, and E Fritsch, and H Frommhold, and D Schönitzer, and J Wiegele, and G Kemmler, and C Huber
February 2002, Journal of immunology (Baltimore, Md. : 1950),
M Berger, and E Irschick, and E Fritsch, and H Frommhold, and D Schönitzer, and J Wiegele, and G Kemmler, and C Huber
February 1981, Nature,
M Berger, and E Irschick, and E Fritsch, and H Frommhold, and D Schönitzer, and J Wiegele, and G Kemmler, and C Huber
December 1982, Journal of immunology (Baltimore, Md. : 1950),
M Berger, and E Irschick, and E Fritsch, and H Frommhold, and D Schönitzer, and J Wiegele, and G Kemmler, and C Huber
July 2004, Breast cancer research and treatment,
M Berger, and E Irschick, and E Fritsch, and H Frommhold, and D Schönitzer, and J Wiegele, and G Kemmler, and C Huber
October 1980, Nature,
Copied contents to your clipboard!